focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Plant Impact Plc

28 Mar 2018 12:00

RNS Number : 2068J
Peel Hunt LLP
28 March 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plant Impact PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Plant Impact PLC

(d) Date dealing undertaken:

27 March 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

319,955

10.40 GBx

10.40 GBx

Ordinary Shares

Sell

100,000

10.45 GBx

10.45 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

28 March 2018

Contact name:

Kathleen Lloyd

Telephone number:

0207 418 8911

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEREAKDPASXPEEF
Date   Source Headline
31st May 20118:30 amRNSTotal Voting Rights
24th May 20117:05 amRNS£2.05 million cash subscription by Arysta
24th May 20117:00 amRNSTrading update
6th Apr 20117:00 amRNSRule 17 disclosure
30th Mar 20118:30 amRNSHolding(s) in Company
11th Mar 20117:00 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSAppointment of new Chairman
30th Dec 20107:00 amRNSDirector/PDMR Shareholding
16th Dec 20109:50 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSHalf Yearly Report
24th Nov 201012:00 pmRNSHolding(s) in Company
18th Nov 20107:00 amRNSGrant of product registrations in Brazil
17th Nov 20107:00 amRNSDistribution and evaluation agreement
19th Oct 201010:30 amRNSHolding(s) in Company
23rd Sep 20107:00 amRNSEvaluation, Development and Distribution Agreement
26th Aug 201011:05 amRNSResult of AGM
25th Aug 20107:00 amRNSField Trials with Syngenta
12th Aug 20107:00 amRNSUpdated trial results
9th Aug 20107:00 amRNSGrant of Awards under LTIP and Share Options
5th Aug 20105:00 pmRNSPosting Annual Report and Accounts and AGM Notice
8th Jul 20102:20 pmRNSAppointment
14th Jun 20107:00 amRNSFinal Results
2nd Jun 20107:00 amRNSDistribution Agreement
29th Apr 20107:00 amRNSNotice of preliminary results and trading update
28th Apr 20107:00 amRNSField trial results
31st Mar 20103:30 pmRNSTotal Voting Rights
29th Mar 20102:46 pmRNSHolding(s) in Company
29th Mar 20102:45 pmRNSHolding(s) in Company
29th Mar 20102:30 pmRNSHolding(s) in Company
12th Mar 201011:15 amRNSResult of General Meeting
25th Feb 20107:00 amRNSIssue of Equity
8th Feb 20107:00 amRNSArysta agreement
3rd Feb 20107:00 amRNSPiNT study results
18th Jan 20107:00 amRNSFinalist at 2010 Grower of the Year Awards
6th Jan 20103:15 pmRNSDirectorate Change
6th Jan 201012:40 pmRNSChange of Adviser
7th Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200911:31 amRNSFurther Field Trial Results
22nd Oct 20097:00 amRNSAward of EU research grant
28th Sep 20097:00 amRNSTrading Statement
10th Sep 200910:36 amRNSHolding(s) in Company
10th Sep 200910:32 amRNSHolding(s) in Company
7th Sep 20098:31 amRNSNew Scientific Advisory Board Announcement
13th Aug 20098:41 amRNSSuccessful Application to Join Committee
6th Aug 20093:58 pmRNSGrant of Options
3rd Aug 20095:15 pmRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
31st Jul 200912:00 pmRNSTotal Voting Rights
30th Jul 200910:20 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.